Evidence map›Paper›PMID 42041872›Full record

ArticleBiology2026

Sorghum Promotes Cell Proliferation Through Activation of the Growth Hormone/IGF-1-JAK2/STAT5b Signaling Axis

Sanghyeon Park, Dong Young Kang, Hyo Tae Kim, Woo-Shik Shin, Sangwon Lee, Jaehoon Cho, Kyoung-Jin Jang

Abstract read
In one paragraph

Article in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sanghyeon ParkDepartment of Immunology, School of Medicine, Konkuk University, Chungju 27478, Republic of Korea.
Dong Young KangDepartment of Integrative Biological Sciences and Industry, College of Life Science, Sejong University, Seoul 05006, Republic of Korea.
Hyo Tae KimR&D Center, NEW&NEW Co., Ltd., Seoul 05855, Republic of Korea.
Woo-Shik ShinLow-Carbon Transition R&D Department, Korea Institute of Industrial Technology (KITECH), Cheonan 31056, Republic of Korea.ORCID 0000-0002-6569-2314
Sangwon LeeDepartment of Integrative Biological Sciences and Industry, College of Life Science, Sejong University, Seoul 05006, Republic of Korea.
Jaehoon ChoLow-Carbon Transition R&D Department, Korea Institute of Industrial Technology (KITECH), Cheonan 31056, Republic of Korea.
Kyoung-Jin JangDepartment of Integrative Biological Sciences and Industry, College of Life Science, Sejong University, Seoul 05006, Republic of Korea.ORCID 0000-0002-4426-4775

Funding

The Ministry of SMEs and Startups (MSS, Republic of Korea) S3452042
6 · The paper itself

Abstract

Sorghum is known for its anti-cancer, anti-inflammatory, and antioxidant properties, but its effect on cell growth is not well understood. First, the cytotoxicity of various sorghum extract (SE) concentrations was evaluated in C2C12 (murine myoblasts) and C3H10T1/2 (murine embryonic fibroblasts). The extent of DNA damage was then assessed, and the activation of the JAK2/STAT5b and IGF-1 pathways was observed. Studies on the transcriptional regulatory function of STAT5b revealed that SE increased STAT5b/DNA binding and transcriptional promoter activity. Consequently, STAT5b upregulation led to the increased expression of IGF-1. Moreover, other factors, such as growth hormone receptor and bone morphogenetic protein 7, were also upregulated. The results of these experiments suggest that sorghum may enhance muscle recovery or promote growth factors by stimulating the JAK2/STAT5b and IGF-1 pathways. Therefore, sorghum is expected to be an effective functional food for bone growth and muscle recovery, without inducing adverse side effects.

Indexed as

C2C12 cellC3H10T1/2 cellIGF-1Jak2/STAT5bsorghum extract

Identifiers

PMID42041872
PMCPMC13112945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.